Monteris Medical
United States
- Minnetonka, MN
- 13/03/2026
- Series E
- $28,000,000
Monteris Medical is the manufacturer of the NeuroBlate® System, the only minimally invasive, robotic, laser interstitial thermal therapy (LITT) that uses MR-guided surgical ablation technology designed specifically for use in the brain. NeuroBlate is an advanced surgical tool designed for precise ablation of brain lesions including primary and metastatic brain tumors, radiation necrosis, and epileptogenic foci for those suffering from drug-resistant epilepsy. NeuroBlate is supported by a strong foundation of prospective multi-center clinical evidence. Patients undergoing a NeuroBlate procedure have demonstrated short hospital stays, minimal complications, and low hospital readmissions.
For full prescribing information, visit https://bit.ly/3pdAg6x. Rx Only.
- Industry Medical Equipment Manufacturing
- Website https://www.monteris.com/
- LinkedIn https://www.linkedin.com/company/monteris-medical/
EnerVenue | $300,000,000 | (Apr 3, 2026)
Acurion, Inc. | $4,300,000 | (Apr 3, 2026)
Gander Robotics | $1,100,000 | (Apr 3, 2026)
daydream | $15,000,000 | (Apr 3, 2026)
Numos | $4,250,000 | (Apr 3, 2026)
Alien | $7,100,000 | (Apr 3, 2026)
Monarch Quantum | $55,000,000 | (Apr 3, 2026)
Sona(UK) | $45,000,000 | (Apr 2, 2026)
Linx Security | $50,000,000 | (Apr 2, 2026)
Earlyasset | $2,000,000 | (Apr 2, 2026)
Rowan(US) | $3,300,000 | (Apr 2, 2026)
Whirl AI | $8,900,000 | (Apr 2, 2026)